Y10S 930/145
Colony stimulating factor
Y10S930/145 (Colony stimulating factor) appears on 37 US grants and 5 published applications in this corpus.
Search patents in Y10S- Granted patents
- 37
- Published applications
- 5
- Assignees
- 19
- Inventors
- 82
- Latest grant
- 23 Sep 2014
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 4 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 3 | 0 |
| 1995 | 4 | 0 |
| 1996 | 2 | 0 |
| 1997 | 5 | 0 |
| 1998 | 2 | 0 |
| 1999 | 3 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 1 |
| 2003 | 1 | 1 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Method for promoting muscle repair comprising administering G-CSF at the site of injury23 Sep 2014US 8,841,250 B2
- Methods for treating HIV-infected patients by the administration of GM-CSF and a protease inhibitor5 Oct 2004US 6,800,280 B2Schering Corporation
- Methods for treating HIV-Infected Patients by the Administration of GM-CSF and a protease inhibitor10 Jun 2003US 6,576,231 B2Schering Corporation
- Mutants of human interleukin-331 Dec 2002US 6,500,417 B1Dsm N. V.
- Recombinant human CSF-1 dimer and compositions thereof27 Nov 2001US 6,322,779 B1Chiron Corporation
- Muscle repair promoter14 Nov 2013US 2013/0302271 A1
- Muscle repair promoter10 May 2012US 2012/0114594 A1Keiichi Fukuda
- Chemically modified G-CSF20 Sep 2007US 2007/0219357 A1Kirin-Amgen, Inc.
- Methods for increasing CD4+ T- lymphocyte counts in HIV-infected patients by the administration of GM-CSF29 May 2003US 2003/0100498 A1Schering Corporation
- Method for increasing cd4+ t-lymphpocyte counts in hiv-infected patients by the administration of gm-csf10 Jan 2002US 2002/0004200 A1Schering Corporation
Most cited
By later US patents
- Conjugation of polymer to colony stimulating factor-1244US 4,847,325 ACetus Corporation · 1989
- Chemically-modified G-CSF195US 5,824,778 AKirin-Amgen, Inc. · 1998
- Analogs of human granulocyte-macrophage colony stimulating factor143US 5,229,496 AImmunex Corporation · 1993
- Analogs of human granulocyte-macrophage colony stimulating factor133US 5,393,870 AImmunex Corporation · 1995
- DNAs encoding analog GM-CSF molecules displaying resistance to proteases which cleave at adjacent dibasic residues132US 5,391,485 AImmunex Corporation · 1995